Background Image
Table of Contents Table of Contents
Previous Page  13 / 30 Next Page
Information
Show Menu
Previous Page 13 / 30 Next Page
Page Background

SA JOURNAL OF DIABETES & VASCULAR DISEASE

RESEARCH ARTICLE

VOLUME 17 NUMBER 2 • NOVEMBER 2020

49

Unless stated otherwise, drugs and chemicals were obtained

from Sigma-Aldrich (SA). Streptozotocin (STZ) was used to induce a

moderate form of diabetes mellitus, as previously described.

14

Rats

were fasted of food (but not water) for six hours to improve the

uptake of STZ before being injected intraperitoneally (i.p.) with STZ

(50 mg/kg). The STZ was freshly dissolved in 0.1 M citrate buffer

(pH 4.5) before administration.

Blood glucose was measured from tail vein blood samples

obtained at similar times of the day using a glucometer (Accu-Chek,

Roche, SA).

14

Rats with a random blood glucose concentration ≥ 15

mmol/l were considered diabetic.

Magnesium was administered as MgSO

4

(270 mg/kg, i.p.)

dissolved in normal saline.

15,16

The i.p. route was chosen for Mg

2+

to achieve more reliable uptake compared to oral administration

in water or food where the uptake may vary in diabetes due to

polydipsia and polyphagia.

The rats were randomly divided into four treatment groups, and

each rat was identified by a unique label on the tail. The control

group was injected i.p. with a single dose of citrate buffer on the first

day, and with saline i.p. once daily for 28 consecutive days. The STZ

group was injected i.p. with a single dose of STZ 50 mg/kg on the

first day, and with saline i.p. once daily for 28 days. The STZ + Mg

2+

group was injected i.p. with a single dose of STZ 50 mg/kg on the

first day, and with MgSO

4

270 mg/kg i.p. once daily for 28 days. The

Mg

2+

group was injected i.p. with a single dose of citrate buffer on

the first day, and with MgSO

4

270 mg/kg i.p. once daily for 28 days.

Rat hearts were surgically removed under anaesthesia to

euthanise the rats, as previously described.

16

Briefly, rats were

anticoagulated with heparin (500 IU/kg, i.p.) and anaesthetised

with sodium pentobarbital (70 mg/kg, i.p., Vetserv, SA). Upon

loss of the pedal withdrawal reflexes, the hearts were excised via

a thoracotomy incision and placed in cold (4°C), filtered (7-μm

pore Whatman filter paper, Sigma-Aldrich, SA), modified Krebs-

Henseleit (KH) solution containing (in mmol/l): 118.5 NaCl, 4.7

KCl, 25 NaHCO

3

, 1.2 MgSO

4

, 1.8 CaCl

2

, 1.2 KH

2

PO

4

and 11 glucose

(pH 7.4). CaCl

2

was added after the optimisation of pH to prevent

precipitation of calcium with phosphate. Some hearts were used

for cardiac perfusion studies, whereas the others were either

histologically analysed or snap-frozen in liquid nitrogen and stored

at –80°C for Western blot analysis.

For perfusion studies, the hearts were retrogradely perfused

with K-H solution through an aortic cannula on a constantpressure

(74 mmHg) Langendorff apparatus. To ensure optimal cardiac

tissue viability, the time lapse between excision of the heart and

commencement of perfusion was limited to three minutes. The K-H

solution was gassed with carbogen (95% O

2

and 5% CO

2

) and

was maintained at 37°C. The coronary flow rate was measured by

collecting coronary effluent over time and was normalised to heart

weight. Blood samples used for Mg

2+

assays were collected at the

time of removal of the heart and centrifuged at 15 000 g (Beckman

microfuge, USA) to obtain plasma, which was frozen until further

analysis.

Electrocardiographic (ECG) and haemodynamic parameters were

measured using the PowerLab data-acquisition system and LabChart

Pro 7 software (ADInstruments, Australia), as previously described.

16

ECG was recorded using apex-to-base electrodes via a transducer

(ML136) and was analysed using the LabChart Pro ECG module

(ADInstruments, Australia). The QT interval, corrected for heart rate

(QTc) was calculated using Bazett’s formula. Left ventricular (LV)

pressure was measured using a water-filled, intraventricular balloon

connected to a pressure transducer (MLT1199) and amplifier

(ML221, ADInstruments, Australia).

The hearts were stabilised for 20 minutes and the LV end-

diastolic pressure (LVEDP) was set at 5–10 mmHg. The LabChart

7 Pro blood pressure module (ADInstruments, Australia) was used

to analyse haemodynamic data and to derive the maximal rate of

pressure increase (+dP/dt

max

), the maximal rate of pressure decline

(–dP/dt

max

), contractility index and the time constant of ventricular

relaxation

(tau)

. The LV developed pressure (LVDP) was calculated

as the difference between LV peak systolic pressure and LVEDP.

Transverse sections of cardiac ventricular tissue were stained

with either haematoxylin and eosin (H&E) or Masson’s trichrome,

as previously described.

16

Histological images were taken using

a charge-coupled device camera (Zeiss AxioCam, Germany)

attached to an optical microscope (Zeiss AxioSkop, Germany). The

cardiomyocyte width on H&E images was analysed using ImageJ

software (NIH, USA). The average width of five cells on each of four

sections of the heart was calculated for each heart. The degree of

interstitial and perivascular fibrosis on Masson’s trichrome images

was semi-quantitatively scored, as done previously,

16

based on a

scoring system described by Buwa

et al

.

17

as follows: none (–), mild

(+), moderate (++), and severe (+++).

Frozen LV tissues were homogenised on ice by sonication in a

modified radioimmunoprecipitation assay buffer (50 mM Tris-HCl,

150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate,

0.1% sodium dodecyl sulphate, pH 7.4) containing a protease/

phosphatase inhibitor cocktail (Thermo Scientific, USA). Protein

concentrations were quantified (Pierce protein assay kit, Thermo

Scientific, USA) and protein samples (40 μg) were loaded and

electrophoresed on 12% sodium dodecyl sulphate-polyacrylamide

gels (Mini-Protean Tetra Cell, BioRad, SA) and transferred to

isopropanol-soaked polyvinylidene fluoride membranes (Trans-Blot

Turbo, Bio-Rad, SA).

The membranes were blocked with 5% bovine serum albumin

(BSA) in 0.1% Tween20 phosphate-buffered saline (PBS-T) for one

hour at room temperature, and incubated with anti-ATP5A mouse

antibody (1:5000, #136178, Santa Cruz Biotechnology, USA) in 5%

BSA in PBS-T overnight at 4°C. The primary antibody was excluded

in the negative control in order to rule out non-specific binding of

the secondary antibody. The membranes were washed with PBST

and incubated with horseradish peroxidase-conjugated secondary

antibody (1:10000, #170-6516, Bio-Rad, SA) in 5% BSA in PBS-T

for two hours at room temperature.

The membranes were then washed with PBS-T, incubated with

enhanced chemiluminescence substrate (Bio-Rad, SA) and exposed

to X-ray film in the dark room. The membranes were stripped,

blocked and re-probed with anti-

β

-actin rabbit antibody (1:10000,

#16039, Abcam, USA) and goat anti-rabbit secondary antibody

(1:10 000, #6721, Abcam, USA). The bands on films were analysed

using ImageJ software (NIH, USA) and were normalised to those of

the housekeeping protein

β

-actin.

The Mg

2+

concentration was measured in the plasma samples

prepared at exsanguination, 18–24 hours after the final dose of

MgSO

4

had been administered. Ionised Mg

2+

concentration was

measured using automated spectrophotometric and potentiometric

analyses (Beckman AU Chemistry Analyzer, PathCare, SA).

14

Statistical analysis

Data are expressed as mean and standard error of the mean

(SEM) or as box plots and the mean, and

n

indicates the number